PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-86238 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Prostate Cancer Diagnostics and Therapy Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET

7.1 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS AND THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Abbvie Inc.

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Astellas Pharma Inc.

16.3 Koninklijke Philips NV

16.4 Dendreon Pharmaceuticals LLC

16.5 Tolmar Inc.

16.6 AstraZeneca PLC

16.7 Sanofi

16.8 Aventis

16.9 Hologic Inc.

16.10 Bayer AG

16.11 Ipsen SA

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Most important types of Prostate Cancer Diagnostics and Therapy products covered in this report are:
Preliminary Tests
Trans-rectal Ultrasound
PCA3 Tests
Biopsy

Most widely used downstream fields of Prostate Cancer Diagnostics and Therapy market covered in this report are:
Specialty Centers
Hospitals & Clinics
others

Companies

Abbvie Inc.
Astellas Pharma Inc.
Koninklijke Philips NV
Dendreon Pharmaceuticals LLC
Tolmar Inc.
AstraZeneca PLC
Sanofi
Aventis
Hologic Inc.
Bayer AG
Ipsen SA

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.